| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acidosis | 5 | 2022 | 271 | 2.610 |
Why?
|
| Hyperammonemia | 5 | 2020 | 80 | 2.090 |
Why?
|
| Renal Dialysis | 26 | 2022 | 1791 | 1.960 |
Why?
|
| Acute Kidney Injury | 9 | 2022 | 1942 | 1.270 |
Why?
|
| Arteriovenous Shunt, Surgical | 5 | 2016 | 291 | 1.160 |
Why?
|
| Acid-Base Imbalance | 3 | 2021 | 41 | 1.150 |
Why?
|
| Acid-Base Equilibrium | 4 | 2022 | 180 | 1.090 |
Why?
|
| Forearm | 2 | 2016 | 427 | 0.840 |
Why?
|
| Antihypertensive Agents | 9 | 2016 | 2029 | 0.830 |
Why?
|
| Kidney Failure, Chronic | 10 | 2017 | 2496 | 0.810 |
Why?
|
| Scurvy | 1 | 2022 | 36 | 0.790 |
Why?
|
| Renal Replacement Therapy | 3 | 2019 | 282 | 0.760 |
Why?
|
| Electrolytes | 2 | 2022 | 279 | 0.720 |
Why?
|
| Amyloidosis | 7 | 2020 | 878 | 0.720 |
Why?
|
| Brachial Artery | 2 | 2016 | 373 | 0.670 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 2019 | 26 | 0.650 |
Why?
|
| 2-Propanol | 1 | 2019 | 28 | 0.640 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2020 | 189 | 0.630 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2020 | 304 | 0.620 |
Why?
|
| Uremia | 1 | 2018 | 202 | 0.580 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2016 | 538 | 0.560 |
Why?
|
| Pericarditis | 1 | 2018 | 136 | 0.560 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 92 | 0.560 |
Why?
|
| Hypertension, Renovascular | 3 | 2006 | 115 | 0.550 |
Why?
|
| Sodium | 1 | 2022 | 1597 | 0.550 |
Why?
|
| Renal Artery Obstruction | 4 | 2013 | 217 | 0.540 |
Why?
|
| Obesity, Morbid | 2 | 2020 | 1298 | 0.540 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 326 | 0.530 |
Why?
|
| Fructose | 1 | 2017 | 284 | 0.500 |
Why?
|
| Hepatic Encephalopathy | 1 | 2016 | 144 | 0.490 |
Why?
|
| Kidney Diseases | 7 | 2017 | 2100 | 0.490 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2015 | 86 | 0.480 |
Why?
|
| Liver Failure, Acute | 1 | 2016 | 182 | 0.470 |
Why?
|
| Hypertension | 10 | 2018 | 8616 | 0.460 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 2014 | 21 | 0.450 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 61 | 0.440 |
Why?
|
| Carboplatin | 1 | 2017 | 797 | 0.440 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2014 | 82 | 0.440 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 1014 | 0.430 |
Why?
|
| Magnesium | 1 | 2017 | 815 | 0.430 |
Why?
|
| Gastric Bypass | 2 | 2015 | 824 | 0.430 |
Why?
|
| Anemia | 1 | 2022 | 1514 | 0.410 |
Why?
|
| Vascular Patency | 4 | 2015 | 917 | 0.390 |
Why?
|
| Scleroderma, Systemic | 1 | 2016 | 346 | 0.390 |
Why?
|
| Kidney Transplantation | 5 | 2020 | 4262 | 0.370 |
Why?
|
| Veins | 1 | 2015 | 769 | 0.370 |
Why?
|
| Hospitalists | 1 | 2015 | 298 | 0.360 |
Why?
|
| Mucormycosis | 6 | 2020 | 102 | 0.360 |
Why?
|
| Hepatitis B | 1 | 2016 | 711 | 0.360 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 6 | 2016 | 1515 | 0.350 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 1001 | 0.340 |
Why?
|
| Emergency Medical Services | 2 | 2016 | 1947 | 0.340 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1406 | 0.320 |
Why?
|
| Organ Transplantation | 1 | 2019 | 1176 | 0.310 |
Why?
|
| Poisoning | 2 | 2020 | 252 | 0.310 |
Why?
|
| Contrast Media | 2 | 2021 | 5330 | 0.300 |
Why?
|
| Anemia, Hemolytic | 2 | 2023 | 164 | 0.300 |
Why?
|
| Alcoholism | 1 | 2019 | 1980 | 0.300 |
Why?
|
| Curriculum | 1 | 2021 | 3782 | 0.290 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2008 | 44 | 0.290 |
Why?
|
| Blood Pressure | 5 | 2016 | 8543 | 0.290 |
Why?
|
| Fibromuscular Dysplasia | 3 | 2006 | 55 | 0.290 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2008 | 80 | 0.280 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2006 | 66 | 0.260 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 1456 | 0.240 |
Why?
|
| Humans | 85 | 2023 | 768166 | 0.240 |
Why?
|
| Thrombosis | 3 | 2016 | 2957 | 0.230 |
Why?
|
| Kidney | 5 | 2020 | 7064 | 0.230 |
Why?
|
| Confusion | 2 | 2023 | 278 | 0.220 |
Why?
|
| Diagnosis, Differential | 11 | 2021 | 13014 | 0.220 |
Why?
|
| Fever | 2 | 2009 | 1614 | 0.210 |
Why?
|
| Osmolar Concentration | 3 | 2021 | 657 | 0.210 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 991 | 0.210 |
Why?
|
| Arm | 1 | 2015 | 591 | 0.200 |
Why?
|
| Vasodilation | 1 | 2016 | 967 | 0.200 |
Why?
|
| Renal Artery | 2 | 2013 | 354 | 0.200 |
Why?
|
| Acidosis, Lactic | 2 | 2021 | 145 | 0.200 |
Why?
|
| Renin-Angiotensin System | 4 | 2009 | 737 | 0.200 |
Why?
|
| Syndrome | 3 | 2018 | 3272 | 0.200 |
Why?
|
| Acetaminophen | 1 | 2006 | 552 | 0.190 |
Why?
|
| Middle Aged | 40 | 2023 | 223492 | 0.190 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2023 | 147 | 0.190 |
Why?
|
| Chloramines | 1 | 2000 | 15 | 0.180 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 428 | 0.180 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2016 | 198 | 0.180 |
Why?
|
| Kidney Function Tests | 2 | 2022 | 684 | 0.180 |
Why?
|
| Glomerulonephritis, Membranous | 2 | 2018 | 86 | 0.180 |
Why?
|
| Methemoglobinemia | 1 | 2000 | 45 | 0.180 |
Why?
|
| Deferoxamine | 4 | 1991 | 155 | 0.170 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2020 | 115 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 7454 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2014 | 1886 | 0.170 |
Why?
|
| Diazepam | 1 | 2020 | 214 | 0.170 |
Why?
|
| Acetone | 1 | 2019 | 44 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 5520 | 0.160 |
Why?
|
| Male | 40 | 2022 | 364719 | 0.160 |
Why?
|
| Kidney Glomerulus | 2 | 2018 | 570 | 0.160 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2004 | 1065 | 0.160 |
Why?
|
| Female | 43 | 2023 | 397192 | 0.160 |
Why?
|
| Brain Abscess | 1 | 2020 | 123 | 0.160 |
Why?
|
| Ultrasonography | 6 | 2020 | 6004 | 0.160 |
Why?
|
| Heart Block | 1 | 2020 | 390 | 0.160 |
Why?
|
| Radiography, Abdominal | 2 | 2019 | 541 | 0.160 |
Why?
|
| Fatal Outcome | 3 | 2016 | 1836 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 658 | 0.160 |
Why?
|
| Adult | 29 | 2021 | 223646 | 0.160 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2018 | 41 | 0.150 |
Why?
|
| Phenobarbital | 1 | 2019 | 192 | 0.150 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2018 | 32 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 2 | 2016 | 1506 | 0.150 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15832 | 0.150 |
Why?
|
| Renal Veins | 1 | 2018 | 103 | 0.150 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2021 | 257 | 0.150 |
Why?
|
| Hematuria | 2 | 2018 | 232 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2021 | 587 | 0.140 |
Why?
|
| Hematoma | 1 | 2022 | 766 | 0.140 |
Why?
|
| Skin Diseases | 2 | 2016 | 1085 | 0.140 |
Why?
|
| Angioplasty, Balloon | 3 | 2013 | 592 | 0.140 |
Why?
|
| Sodium Chloride | 2 | 2016 | 584 | 0.140 |
Why?
|
| Decerebrate State | 1 | 2016 | 42 | 0.140 |
Why?
|
| Tachycardia | 1 | 2019 | 599 | 0.140 |
Why?
|
| Cushing Syndrome | 1 | 2018 | 241 | 0.130 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
| Heparin Antagonists | 1 | 2016 | 34 | 0.130 |
Why?
|
| Thiosulfates | 1 | 2016 | 52 | 0.130 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 472 | 0.130 |
Why?
|
| Facial Paralysis | 1 | 2020 | 346 | 0.130 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2016 | 141 | 0.130 |
Why?
|
| Dipyridamole | 3 | 2012 | 143 | 0.130 |
Why?
|
| Metformin | 2 | 2021 | 909 | 0.130 |
Why?
|
| Physical Examination | 2 | 2016 | 1263 | 0.130 |
Why?
|
| Leiomyomatosis | 1 | 2016 | 69 | 0.130 |
Why?
|
| Beer | 1 | 1996 | 135 | 0.130 |
Why?
|
| Thymus Neoplasms | 1 | 2018 | 274 | 0.130 |
Why?
|
| Protamines | 1 | 2016 | 112 | 0.130 |
Why?
|
| Anuria | 1 | 2015 | 15 | 0.120 |
Why?
|
| Azotemia | 1 | 2015 | 8 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 530 | 0.120 |
Why?
|
| Radiography | 4 | 2016 | 6983 | 0.120 |
Why?
|
| Ammonia | 1 | 2016 | 247 | 0.120 |
Why?
|
| Opportunistic Infections | 2 | 1988 | 375 | 0.120 |
Why?
|
| Aged | 24 | 2023 | 171504 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 1126 | 0.120 |
Why?
|
| Liver Function Tests | 1 | 2016 | 526 | 0.120 |
Why?
|
| Gallbladder | 1 | 2016 | 308 | 0.120 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2016 | 154 | 0.120 |
Why?
|
| Chelating Agents | 1 | 2016 | 385 | 0.120 |
Why?
|
| Unconsciousness | 1 | 2016 | 251 | 0.110 |
Why?
|
| Duffy Blood-Group System | 1 | 2014 | 61 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 812 | 0.110 |
Why?
|
| Calciphylaxis | 1 | 2016 | 129 | 0.110 |
Why?
|
| Syncope | 1 | 2017 | 430 | 0.110 |
Why?
|
| Blood Group Incompatibility | 1 | 2014 | 134 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 802 | 0.110 |
Why?
|
| Vitamins | 1 | 2022 | 1638 | 0.110 |
Why?
|
| Radioisotope Renography | 2 | 2006 | 61 | 0.110 |
Why?
|
| Brain | 2 | 2020 | 27360 | 0.110 |
Why?
|
| Hyponatremia | 1 | 1996 | 279 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2017 | 376 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 3 | 2015 | 2227 | 0.100 |
Why?
|
| Prisoners | 1 | 2016 | 316 | 0.100 |
Why?
|
| Ethanol | 1 | 2019 | 1331 | 0.100 |
Why?
|
| Creatine | 1 | 2015 | 427 | 0.100 |
Why?
|
| Drug Eruptions | 1 | 2016 | 335 | 0.100 |
Why?
|
| Diarrhea | 2 | 2021 | 1320 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 1191 | 0.100 |
Why?
|
| Risk Factors | 11 | 2016 | 74944 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 659 | 0.100 |
Why?
|
| Stents | 1 | 2013 | 3195 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 6526 | 0.090 |
Why?
|
| Vomiting | 1 | 2015 | 655 | 0.090 |
Why?
|
| Factor V | 1 | 2012 | 168 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 606 | 0.090 |
Why?
|
| Medical History Taking | 1 | 2015 | 779 | 0.090 |
Why?
|
| Hypoglycemic Agents | 2 | 2021 | 3109 | 0.090 |
Why?
|
| Acute Disease | 2 | 2018 | 7243 | 0.090 |
Why?
|
| Aspirin | 3 | 2012 | 3135 | 0.090 |
Why?
|
| Vascular Grafting | 1 | 2012 | 163 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 1208 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2012 | 2763 | 0.080 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 59629 | 0.080 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 575 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 1429 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3436 | 0.080 |
Why?
|
| Migraine Disorders | 2 | 2017 | 1713 | 0.080 |
Why?
|
| Adenovirus Infections, Human | 1 | 2009 | 76 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2016 | 895 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 1323 | 0.080 |
Why?
|
| Cytosine | 1 | 2009 | 213 | 0.080 |
Why?
|
| Chronic Disease | 5 | 2017 | 9384 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2013 | 1110 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 20760 | 0.070 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2017 | 1188 | 0.070 |
Why?
|
| Prognosis | 5 | 2016 | 30010 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 1424 | 0.070 |
Why?
|
| Hypertension, Malignant | 1 | 2006 | 17 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2016 | 2298 | 0.070 |
Why?
|
| Auscultation | 1 | 2006 | 38 | 0.070 |
Why?
|
| Nephrotic Syndrome | 2 | 2018 | 381 | 0.070 |
Why?
|
| Plethysmography | 1 | 2016 | 172 | 0.070 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 687 | 0.070 |
Why?
|
| Survivors | 1 | 2017 | 2381 | 0.070 |
Why?
|
| Bone Cysts | 1 | 1986 | 48 | 0.060 |
Why?
|
| Captopril | 1 | 2006 | 262 | 0.060 |
Why?
|
| Drug Resistance | 2 | 2014 | 1599 | 0.060 |
Why?
|
| Time Factors | 4 | 2016 | 40218 | 0.060 |
Why?
|
| Nitroglycerin | 1 | 2016 | 332 | 0.060 |
Why?
|
| Angiotensin II | 2 | 2006 | 843 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2819 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2006 | 331 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12543 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 667 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2271 | 0.060 |
Why?
|
| Legionnaires' Disease | 1 | 1985 | 50 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2017 | 2517 | 0.060 |
Why?
|
| Sex Factors | 2 | 2016 | 10632 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2006 | 273 | 0.060 |
Why?
|
| United States | 8 | 2016 | 73039 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 2599 | 0.060 |
Why?
|
| Celiac Artery | 1 | 2004 | 65 | 0.060 |
Why?
|
| Treatment Outcome | 8 | 2016 | 65371 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 463 | 0.060 |
Why?
|
| Renin | 1 | 2006 | 648 | 0.060 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2004 | 93 | 0.060 |
Why?
|
| Angiography | 2 | 2006 | 1597 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1243 | 0.050 |
Why?
|
| Amlodipine | 1 | 2013 | 84 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2016 | 54926 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2016 | 9669 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2013 | 2661 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 1996 | 4045 | 0.050 |
Why?
|
| Lung | 3 | 2018 | 10099 | 0.050 |
Why?
|
| Kidney Tubular Necrosis, Acute | 2 | 1997 | 64 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2931 | 0.050 |
Why?
|
| Graft Rejection | 2 | 2015 | 4492 | 0.050 |
Why?
|
| Spinal Diseases | 1 | 1987 | 561 | 0.050 |
Why?
|
| Drug Combinations | 2 | 2013 | 2089 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 1375 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 990 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12077 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3620 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 3929 | 0.050 |
Why?
|
| Heptanoic Acids | 1 | 2013 | 344 | 0.050 |
Why?
|
| Lithium | 1 | 1984 | 600 | 0.050 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2002 | 111 | 0.050 |
Why?
|
| Hemodialysis Solutions | 1 | 2000 | 7 | 0.050 |
Why?
|
| Logistic Models | 1 | 2016 | 13290 | 0.050 |
Why?
|
| Comorbidity | 1 | 2016 | 10590 | 0.050 |
Why?
|
| Hemolysis | 1 | 2023 | 417 | 0.050 |
Why?
|
| Arthritis | 1 | 1986 | 684 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 15869 | 0.040 |
Why?
|
| Dysarthria | 1 | 2020 | 56 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15454 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 2020 | 173 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2015 | 81762 | 0.040 |
Why?
|
| Analgesics | 1 | 2006 | 1071 | 0.040 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 161 | 0.040 |
Why?
|
| Quality of Life | 1 | 2020 | 13490 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 10399 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 682 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 333 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22291 | 0.040 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2001 | 336 | 0.040 |
Why?
|
| Creatinine | 2 | 2021 | 1918 | 0.040 |
Why?
|
| Brucellosis | 1 | 1997 | 21 | 0.040 |
Why?
|
| Ischemia | 1 | 2006 | 1900 | 0.040 |
Why?
|
| Pyrroles | 1 | 2013 | 1124 | 0.040 |
Why?
|
| Graves Disease | 1 | 1999 | 239 | 0.040 |
Why?
|
| Biopsy | 2 | 2018 | 6793 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2009 | 3073 | 0.030 |
Why?
|
| Pancytopenia | 1 | 1997 | 102 | 0.030 |
Why?
|
| Nail-Patella Syndrome | 1 | 2016 | 12 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2013 | 972 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2015 | 24315 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2018 | 619 | 0.030 |
Why?
|
| Diphosphonates | 1 | 2001 | 634 | 0.030 |
Why?
|
| Abdominal Pain | 2 | 2018 | 1070 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 5863 | 0.030 |
Why?
|
| Ramipril | 1 | 1996 | 102 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 5884 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 370 | 0.030 |
Why?
|
| Heart Failure | 2 | 2021 | 11879 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 10873 | 0.030 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2016 | 45 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1997 | 350 | 0.030 |
Why?
|
| Diverticulitis | 1 | 2018 | 187 | 0.030 |
Why?
|
| Drug Therapy, Combination | 3 | 2011 | 6316 | 0.030 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2016 | 40 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2018 | 557 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2018 | 591 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 15948 | 0.030 |
Why?
|
| Fabry Disease | 1 | 2016 | 89 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2015 | 4194 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1999 | 1034 | 0.030 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2016 | 115 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 2016 | 130 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 60066 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 14729 | 0.030 |
Why?
|
| Edema | 1 | 2018 | 765 | 0.030 |
Why?
|
| Podocytes | 1 | 2018 | 403 | 0.030 |
Why?
|
| Disease Progression | 3 | 2005 | 13671 | 0.030 |
Why?
|
| Diuretics | 1 | 1997 | 614 | 0.030 |
Why?
|
| Premedication | 1 | 2014 | 246 | 0.030 |
Why?
|
| Longevity | 1 | 2001 | 1077 | 0.030 |
Why?
|
| Cholecystitis | 1 | 2014 | 181 | 0.030 |
Why?
|
| Proteinuria | 1 | 1996 | 611 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2016 | 249 | 0.030 |
Why?
|
| Leg | 1 | 2018 | 1088 | 0.030 |
Why?
|
| Hematocrit | 1 | 2014 | 623 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 39348 | 0.030 |
Why?
|
| Graft Survival | 2 | 2015 | 3887 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 16045 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 1996 | 426 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2016 | 313 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8542 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2014 | 418 | 0.020 |
Why?
|
| Double-Blind Method | 4 | 2012 | 12465 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 646 | 0.020 |
Why?
|
| Fatigue | 1 | 2018 | 1557 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 2016 | 561 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2014 | 681 | 0.020 |
Why?
|
| Amyloid | 2 | 1986 | 854 | 0.020 |
Why?
|
| Albuminuria | 2 | 2009 | 658 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2014 | 718 | 0.020 |
Why?
|
| Cardiovascular Diseases | 3 | 2013 | 15662 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1500 | 0.020 |
Why?
|
| Immunoelectrophoresis | 1 | 2009 | 94 | 0.020 |
Why?
|
| Bence Jones Protein | 1 | 2009 | 19 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2018 | 2121 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 10760 | 0.020 |
Why?
|
| Adolescent | 4 | 2015 | 89169 | 0.020 |
Why?
|
| Rhizopus | 1 | 1987 | 21 | 0.020 |
Why?
|
| Incidence | 3 | 2015 | 21538 | 0.020 |
Why?
|
| Tuberous Sclerosis | 1 | 2016 | 1042 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2012 | 683 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 1989 | 313 | 0.020 |
Why?
|
| Hemosiderosis | 1 | 1987 | 66 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2020 | 6412 | 0.020 |
Why?
|
| Aluminum | 1 | 1987 | 150 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2016 | 1554 | 0.020 |
Why?
|
| Anticoagulants | 2 | 2018 | 4852 | 0.020 |
Why?
|
| Dyspnea | 1 | 2014 | 1352 | 0.020 |
Why?
|
| Dialysis | 1 | 2006 | 72 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2014 | 1032 | 0.020 |
Why?
|
| Tenosynovitis | 1 | 1986 | 57 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2016 | 41754 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1798 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2013 | 1043 | 0.020 |
Why?
|
| Carpal Bones | 1 | 1986 | 77 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2009 | 969 | 0.020 |
Why?
|
| Obesity | 1 | 2008 | 13090 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2009 | 1092 | 0.020 |
Why?
|
| Legionella | 1 | 1985 | 27 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 26379 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 1985 | 330 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5151 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2009 | 863 | 0.010 |
Why?
|
| Encephalitis | 1 | 1987 | 441 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4206 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 2001 | 2560 | 0.010 |
Why?
|
| Laparotomy | 1 | 2004 | 458 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1985 | 344 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6568 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7951 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2002 | 435 | 0.010 |
Why?
|
| Europe | 1 | 1987 | 3436 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 8080 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3252 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 12252 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2004 | 806 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 11095 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1622 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2004 | 856 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2001 | 994 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2005 | 1320 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13676 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7214 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18412 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1997 | 84 | 0.010 |
Why?
|
| Multiple Myeloma | 2 | 2009 | 5196 | 0.010 |
Why?
|
| Oliguria | 1 | 1997 | 20 | 0.010 |
Why?
|
| Research Design | 1 | 2013 | 6211 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2004 | 973 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7477 | 0.010 |
Why?
|
| Renal Plasma Flow | 1 | 1996 | 27 | 0.010 |
Why?
|
| Registries | 2 | 1991 | 8375 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1997 | 192 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2001 | 10101 | 0.010 |
Why?
|
| Mexican Americans | 1 | 1997 | 165 | 0.010 |
Why?
|
| Texas | 1 | 1997 | 410 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26422 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 36743 | 0.010 |
Why?
|
| Diabetes Mellitus | 2 | 2005 | 5889 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 2230 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30238 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1996 | 2107 | 0.010 |
Why?
|
| HIV Infections | 1 | 2014 | 17569 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20227 | 0.000 |
Why?
|
| Bipolar Disorder | 1 | 1984 | 5130 | 0.000 |
Why?
|
| Child | 1 | 2015 | 80917 | 0.000 |
Why?
|
| Chemistry | 1 | 1985 | 327 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 486 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 11519 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1985 | 1134 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1989 | 4030 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1985 | 1081 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 21206 | 0.000 |
Why?
|